Drug Resistance Updates

Aims & Scope

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.

Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication.

Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article.

The goal is to highlight recent areas of growth and put them in perspective. *Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	21.7
2024	15.80

Journal Rank

Year	Value
2024	270

Journal Citation Indicator

Year	Value
2024	2883

SJR (SCImago Journal Rank)

Year	Value
2024	5.282

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	139

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• ROS stress in cancer cells and therapeutic implications

  Citation: 1643

  Authors: Helene, Dennis, Peng

• Aminoglycoside modifying enzymes

  Citation: 1089

  Authors: Maria S., Marcelo E.

• Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

  Citation: 828

  Authors: O., B., M.C., P., T., H.E.

• Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

  Citation: 627

  Authors: Jaclyn, Gideon M., Wendy B., Phillip A.

• The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade

  Citation: 596

  Authors: Rishil J., Pranav, Charles R., Zhe-Sheng

• If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells

  Citation: 587

  Authors: Igor B., Eugenia V., Bey-Dih

• Mechanisms and consequences of bacterial resistance to antimicrobial peptides

  Citation: 577

  Authors: D.I., D., J.Z.

• Modulating ROS to overcome multidrug resistance in cancer

  Citation: 561

  Authors: Qingbin, Jing-Quan, Yehuda G., Liang, Pranav, Liuya, Charles R., Dong-Hua, Zhe-Sheng

• Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies

  Citation: 548

  Authors: Wen, Han, Yehuda G., Kun, Xiaojun, Jinbing, Dong-Hua, Zhe-Sheng

• The increasing threat of Pseudomonas aeruginosa high-risk clones

  Citation: 524

  Authors: Antonio, Xavier, Carla, Carlos

---